1. Ames, R. S., Li, Y., Sarau, H. M., Nuthulaganti, P., Foley, J. J., Ellis, C., Zeng, Z., Su, K., Jurewicz, A. J., Hertzberg, R. P. et al. (1996) Molecular cloning and characterization of the human anaphylatoxin C3a receptor J. Biol. Chem 271: 20231–20234.
2. Ando, B., Wiedmer, T., Hamilton, K. K., and Sims, P.J. (1988) Complement proteins C5b-9 initiate secretion of platelet storage granules without increased binding of fibrinogen or von Willebrand factor to newly expressed cell surface GPIIb—IIIa. J. Biol. Chem. 263: 11907–11914.
3. Biesecker, G., and Gomez, C. M. (1989) Inhibition of acute passive transfer experimental autoimmune myasthenia gravis with Fab antibody to complement C6. J. Immunol. 142: 2654–2659.
4. Bitter-Suermann, D. (1982) Contribution of complement factors and reaction pathways to inflammation Agents Actions Suppl. 11: 159–178.
5. Bokisch, V. A., and Muller-Eberhard, H. J., (1970) Anaphylatoxin inactivator of human plasma its isolation and characterization as a carboxypeptidase. J. Clin. Invest. 49: 2427–2436.